Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barney Graham

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Science Immunology|June 16, 2021
SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus MacaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.
The Lancet. Infectious Diseases|November 8, 2015
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trialMilagritos D Tapia, Samba O Sow, Kirsten E Lyke, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Science Immunology|June 16, 2021
SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus MacaquesCarolina Garrido, Alan D Curtis, Maria Dennis, et al.
The Lancet. Infectious Diseases|November 8, 2015
Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trialMilagritos D Tapia, Samba O Sow, Kirsten E Lyke, et al.
Pageof 2